학술논문

Loss of Extreme Long-Range Enhancers in Human Neural Crest Drives a Craniofacial Disorder
Document Type
article
Source
Cell Stem Cell. 27(5)
Subject
Biological Sciences
Biomedical and Clinical Sciences
Genetics
Stem Cell Research
Congenital Structural Anomalies
Pediatric
Stem Cell Research - Nonembryonic - Human
Biotechnology
Stem Cell Research - Embryonic - Human
Dental/Oral and Craniofacial Disease
1.1 Normal biological development and functioning
Cell Differentiation
Humans
Mutation
Neural Crest
Pierre Robin Syndrome
Regulatory Sequences
Nucleic Acid
SOX9 Transcription Factor
Pierre Robin sequence
SOX9
craniofacial
enhancer
enhanceropathy
gene dosage
long-range regulation
neural crest
non-coding mutation
transcription
Medical and Health Sciences
Developmental Biology
Biological sciences
Biomedical and clinical sciences
Language
Abstract
Non-coding mutations at the far end of a large gene desert surrounding the SOX9 gene result in a human craniofacial disorder called Pierre Robin sequence (PRS). Leveraging a human stem cell differentiation model, we identify two clusters of enhancers within the PRS-associated region that regulate SOX9 expression during a restricted window of facial progenitor development at distances up to 1.45 Mb. Enhancers within the 1.45 Mb cluster exhibit highly synergistic activity that is dependent on the Coordinator motif. Using mouse models, we demonstrate that PRS phenotypic specificity arises from the convergence of two mechanisms: confinement of Sox9 dosage perturbation to developing facial structures through context-specific enhancer activity and heightened sensitivity of the lower jaw to Sox9 expression reduction. Overall, we characterize the longest-range human enhancers involved in congenital malformations, directly demonstrate that PRS is an enhanceropathy, and illustrate how small changes in gene expression can lead to morphological variation.